| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2024 , Vol 62 , Num 2
Study of formulation effects on the charge variant profile of antibody-maytansine conjugates by icIEF method
1 Department of Medicinal Chemistry and Quality Control, Faculty of Pharmacy, Tishreen University, Lattakia, Syria
DOI :
10.23893/1307-2080.APS6219